We are excited to exhibit in CPHI Japan which will be held at Tokyo Big Sight, Tokyo, Japan from 19-21 April 2023.
You may please visit us at our stand 6C-30 for more business opportunities.
Categories
Exhibiting in CPHI- Japan
Category: News
We, Chemical Resources are the Finalist of CPHI Pharma Awards 2022 for API Development product- Thiocolchicoside
Chereso has developed an in-house fermentation method to gear especially towards production
of Thiocolchiocosides among its wide array of premium quality ingredients. With our expanded
manufacturing capacities, we are a reliable partner to provide this product with credibility.
Supported by:
- Certificate of Suitability (CEP)
- US DMF – 32070
CHERESO continued its successful presence as an exhibitor at CPhI- Worldwide which is the world’s largest global pharmaceutical exhibition. It was held at Messe Frankfurt, Germany from 1 – 3 November 2022 and united thousands of pharma professionals and suppliers from more than 170 countries, in the presence of more than 1,400 international exhibitors.
CHERESO got the opportunity to engage with the global pharmaceutical community and present the innovative and specialty products developed and manufactured by our Organization.
Categories
Exhibited at Vitafoods Europe- 2022
Exhibited at Vitafoods- Europe 2022 after a long period with full enthusiasm & fantastic meetings.
Introduced our innovative products & explore more opportunities to grow.
We have been granted the following Patents for ‘A Single herb extract for the treatment of PCOS (Polycystic Ovarian Syndrome)’
| Country | Patent No. |
| FRANCE & POLAND | EP3233100B1 |
| GERMANY | 602015070972.1 |
| ITALY | 502021000080333 |
| CHINA | CN109152729B |
Categories
Proud moment for our research scholar
It is an immense pleasure to share this news that our Research Scholar – Ms. Manpreet Kaur working under the Prime Minister Research Fellowship (an initiative of FICCI and SERB) with our company on the topic “Biochemical Characterization of Euryhaline Microalgal Strina for Bioactive Metabolites” under the guidance of Dr Surekha Bhatia, Senior Biochemist, department of processing & food engineering has been awarded the “Best Research Scholar Award- 2021 in Plant Biochemistry” at 3rd International Conference Global Initiative in Agriculture, Forestry and Life Science (GIAFAS-2021) by Dr US Ravat, Vice-Chancellor, SGRRU and Dr. A P Garg.
She has been invited as a Short Term Scholar in the lab of Dr. Eric A. Decker, Head, Department of Food Science, University of Massachusetts, Amherst, USA for six months to work on the stability of food lipids.
Fenfuro abstract title: Clinical study to determine efficacy of trigonella foenum-graecum extract in patients with type 2 diabetes selected for poster presentation at IDF Diabetes Complications Congress 2018, on 25 to 27 October at the Hyderabad International Convention Centre, Hyderabad, India.
TEAM FENFURO participated in BPCON 2013 – 23rd annual meeting of Indian society for Hypertension held at scientific convention center of King George’s Medical University Lucknow, Uttar Pradesh from 16th to 17th November 2013.
Around 20 international and 20 national faculty of repute came together to bridge the gap of research and clinic and it was attended by approximately 1000 physicians, diabetologist and cardiologists of our country.
1. Society of Toxicology SOT 2014, Phoenix, AZ
March 24, 2014, 9:30 AM to 12:30 PM
CHEMICAL RESOURCES & CEPHAM INC. R&D team presented “Safety, Efficacy and Toxicological Evaluation of a Novel, Patented Anti-Diabetic Extract of Trigonella Foenum-graceum Seed Extract (CR001810)”
The paper and poster generated very favorable response from R&D Teams of Coca-Cola, Pepsico, United States Coast Guard Academy, United States Army Institute of Public Health & United States Food & Drug Administration.
2. KOREA Natural Product Conference, Mokpo, South Korea
April 18, 2014
Invited speaker Dr. Debasis Bagchi, Chief Scientific Officer, Cepham Inc presented a paper titled: “Anti-oxidant and Anti-Diabetic Efficacy of Novel Green Coffee Bean (GCB-70) and TrigonellaFoenum Extracts (FENFURO™)”
The scientific paper and Q&A session followed by the presentation generated a positive response from more than 50 eminent scientists from all over the world present during this session in port city of Mokpo, South Korea.
3. Experimental Biology EB 2014, San Diego, CA
April 29, 2014
CHEMICAL RESOURCES & CEPHAM INC. R&D team presented two abstracts on FENFURO™ and GCB70™ on April 29, 2014.
“Efficacy of a Novel Green Coffee Bean Extract (GCB70™) in Weight Management” & “Anti-Diabetic Efficacy of Fenfuro™, a Novel Trigonella Foenum-Gracium Seed Extract”
4. Vitafoods 2014 Geneva, Switzerland
May 7, 2014 16:10 – 16:35hrs
Chemical Resources & Cepham Inc R&D team led by Dr. Debasis Bagchi presented:
Anti-Diabetic Efficacy of FENFURO™, a Novel Fenugreek Extract
- A novel, natural extract of Trigonella Foenum-graecum seed extract (Fenfuro™), enriched in furostanolic saponins.
- Toxicity and mutagenicity studies demonstrated the broad spectrum safety.
- Exhibited significant efficacy in lowering plasma triglyceride and glycosylated hemoglobin levels in diabetic animals.
- FENFURO exhibited potent hypoglycemic activity.
- Comparable anti-diabetic efficacy with other allopathic medicines
The session was chaired by Prof. Robert Thomas, Addenbrooke’s Hospital, Cambridge University, UK.
TEAM FENFURO participated in 6th World Ayurveda Congress & Arogya held at Pragati Maidan, New Delhi from 06th to 09thNovember 2014.
Free catalogues/informative material were distributed among visitors for awareness of Diabetes and its complications, Obesity, PCOS(ploycystic ovarian syndrome) & General Health.
